Neurovive Pharmaceutical: NeuroVive and Arbutus Sign Termination Agreement - Business Wire (press release)

Neurovive Pharmaceutical: NeuroVive and Arbutus Sign Termination Agreement
Business Wire (press release)
NeuroVive Pharmaceutical AB (Nasdaq Stockholm: NVP, OTCQX: NEVPF), the mitochondrial medicine company, today announces that the license agreement with Arbutus Biopharma (formerly OnCore Biopharma, Inc.) has been terminated and all rights to ...and more »